Showing results (311-320 of 367) with videos related to

Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|March 21, 2009
Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: a prospective, multicenter trialHui-Young Lee, Myung-Ju Ahn, Yeon Hee Park, et al.
The New England Journal of Medicine|May 31, 2023
Capivasertib in Hormone Receptor-Positive Advanced Breast CancerNicholas C Turner, Mafalda Oliveira, Sacha J Howell, et al.
The New England Journal of Medicine|December 12, 2019
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast CancerShanu Modi, Cristina Saura, Toshinari Yamashita, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2023
Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trialDae-Won Lee, Kyung Hae Jung, Kyung-Hun Lee, et al.
Cancer Research and Treatment|April 2, 2016
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort StudySe Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.
The Lancet. Oncology|August 30, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trialMafalda Oliveira, Hope S Rugo, Sacha J Howell, et al.
Cancer Letters|October 16, 2007
Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter studySung Yong Oh, Hyuk-Chan Kwon, Won Seog Kim, et al.
Cancer Research and Treatment|July 10, 2025
Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast CancerSeung Ah Lee, Ki Jo Kim, Do Youn Woen, et al.
The Lancet. Oncology|September 1, 2023
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 studySara A Hurvitz, Aditya Bardia, Vanesa Quiroga, et al.
Pageof 37